Literature DB >> 2430831

Immunoactive chimeric ST-LT enterotoxins of Escherichia coli generated by in vitro gene fusion.

J Sanchez, B E Uhlin, T Grundström, J Holmgren, T R Hirst.   

Abstract

Two different lengths of the gene encoding Escherichia coli heat-stable toxin (STa) were fused to the carboxy end of the gene coding for the E. coli heat-labile toxin A-subunit (LTA). The hybrid genes directed expression of chimeric LTA-STa proteins. Association of these chimeras with native heat-labile toxin B-subunit (LTB) resulted in protein complexes that bound to GM1 ganglioside and thereby could be assayed in a GM1 ELISA. The complexes reacted with monoclonal antibodies against either LTA, LTB or STa indicating that the STa and LT epitopes remained immunologically intact after fusion. Genetically constructed chimeric proteins exhibiting LT and STa antigens on the same molecule may represent a promising approach to development of broadly protective immunoprophylactic agents and/or useful immunodiagnostic reagents for diarrhoeal diseases caused by enterotoxinogenic E. coli.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430831     DOI: 10.1016/0014-5793(86)81016-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.

Authors:  Arne Taxt; Rein Aasland; Halvor Sommerfelt; James Nataro; Pål Puntervoll
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

2.  Fusion of genes encoding Escherichia coli heat-stable enterotoxin and outer membrane protein OmpC.

Authors:  H T Saarilahti; E T Palva; J Holmgren; J Sanchez
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Development of an immunoassay using recombinant maltose-binding protein-STa fusions for quantitating antibody responses against STa, the heat-stable enterotoxin of Escherichia coli.

Authors:  R Aitken; T R Hirst
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

4.  Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

Authors:  J Sanchez; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli.

Authors:  Nasr-Eldin M Aref; A Mahdi Saeed
Journal:  Vaccine       Date:  2012-07-02       Impact factor: 3.641

6.  Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras.

Authors:  M G Jobling; R K Holmes
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.

Authors:  Mei Liu; Xiaosai Ruan; Chengxian Zhang; Steve R Lawson; David E Knudsen; James P Nataro; Donald C Robertson; Weiping Zhang
Journal:  Infect Immun       Date:  2011-07-25       Impact factor: 3.441

8.  Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.

Authors:  J D Clements
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

9.  Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin.

Authors:  Y Lobet; C W Cluff; W Cieplak
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.

Authors:  Weiping Zhang; Chengxian Zhang; David H Francis; Ying Fang; David Knudsen; James P Nataro; Donald C Robertson
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.